New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 27.90 Min. order: 1 piece ★★★★★ 4.7 (278 reviews) Sold : Login>>
Updates in Medicine | 🔬 REDEFINE 2: CagriSema in T2D + Obesity Original article link in bio 👥 Phase 3a RCT in 1206 adults with T2D (BMI ≥27, HbA1c 7–10%) 💉 US$ 24.25 Min. order: 1 piece ★★★★★ 4.5 (229 reviews) Sold : Login>>
Cagrilintide & Semaglutide in Overweight Adults (REDEFINE-1) | NEJM US$ 29.07 Min. order: 1 piece ★★★★★ 4.4 (97 reviews) Sold : Login>>
Co-formulation of Semaglutide and Cagrilintide Shows Promise Against Diabetes and Obesity US$ 24.70 Min. order: 1 piece ★★★★★ 4.0 (246 reviews) Sold : Login>>
Weight Loss Efficacy of Cagrilintide and Semaglutide US$ 25.82 Min. order: 1 piece ★★★★★ 4.3 (279 reviews) Sold : Login>>